期刊文献+

应正确合理地应用平喘药物 被引量:3

原文传递
导出
摘要 支气管哮喘(简称哮喘)是一种慢性气道炎症性疾病。因环境因素与哮喘的发病有关,除需要避免接触可能诱发哮喘的各种变应原和刺激物外,药物疗法仍是治疗哮喘的最基本、最重要的方法。如果诊断明确,合理应用平喘药物,不仅可使90%以上的哮喘患者的病情获得临床控制,还可使药物引起的不良反应尽可能减轻。反之,不仅无法使哮喘病情获得控制(甚至更加严重),还可引起药源性疾病,使患者的健康“雪上加霜”。以下是哮喘药物治疗中的常见误区及对策。
作者 殷凯生
出处 《国际呼吸杂志》 2009年第1期1-4,共4页 International Journal of Respiration
  • 相关文献

参考文献5

二级参考文献13

  • 1殷凯生.我国支气管哮喘防治中值得重视的几个问题[J].现代医学,2005,33(2):71-73. 被引量:36
  • 2钟南山.我国支气管哮喘防治研究重点及努力方向[J].中华结核和呼吸杂志,2005,28(12):809-811. 被引量:76
  • 3刘春涛.支气管哮喘临床研究中应当重视的一些问题[J].中华结核和呼吸杂志,2005,28(12):815-816. 被引量:2
  • 4[2]Peter L,Gillian S.The relationship between FEV1 and PEF in the assessment of the severity of airways obstruction[J].Respirology,2002,7:333-337.
  • 5[3]Swanney M.FEV6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction[J].Am J Respir Crit Care Med,2000,162:917-919.
  • 6[4]Blecker ER.Similarities and differences in asthma and COPD The Dutch hypothesis[J].Chest,2004,126(2):93s-95s.
  • 7[5]NIH(NHLBI)/ WHO.Global strategy for asthma management and prevention.Global initiative for asthma(GINA).2006,www.ginasthma.org.
  • 8[6]James A.Airway remodeling in asthma[J].Curr Opin Pulm Med,2005,11(1):1-6.
  • 9[7]Till-Leblond I,Gosset P,Tonnel AB.Inflammatory events in severe acute asthma[J].Allergy,2005,60(1):23-29.
  • 10[8]Vaquerizo MJ,Casan P,Castillo,et al.Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma[J].Thorax,2003,58(3):204-210.

共引文献65

同被引文献31

  • 1Nayaka. Areview of montelukast in the treatment of asthma and allergic rhinitis [J]. Expert Opin Pharmacother,2002,5(3):679.
  • 2中华医学会儿科分会呼吸学组 中华儿科杂志编辑委员会.儿童支气管哮喘诊断与防治指南.中华儿科杂志,2008,46:745-745.
  • 3Bisgasrd H,Nielsen K G.Bronchoproteetion with a leukotriene receptor antagonize in asthmatic preschool children[J].Am J Respir Grit Care Med,2000,162(2):187-190.
  • 4管金翠 杨明辉 田莉薇.舒喘灵加敏迪治疗小儿咳嗽变异型哮喘疗效观察.临床荟萃,1999,14(4):174-174.
  • 5Global initiative for asthma. Global Strategy For Asthma Management And Prevention[ S]. America, 2011 : 1-124.
  • 6Spears M, Donnelly I, Jolly L, et al. Effect of low-dose theophylline plus beclomethasone on lung function in smokers with asthma: a pilotstudy[J]. Eur Respir J, 2009, 33(5) : 1010-1017.
  • 7Hatzeimann A, Morcillo EJ, Lungarella G, et al. The preclinical pharmacology of roflumilast-a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease [J]. Pulm Pharmaeol Ther, 2010, 23(4) : 235-256.
  • 8Barnes N, Pavord I, Chuchalin A, et al. A randomized, doubleblind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma [ J ]. Clin Exp Allergy, 2012, 42 ( 1 ) : 38-48.
  • 9Pettipher R, Hunter MG, Perkins CM, et al. Heightened response of eosinophilie asthmatic patients to the CRTH2 antagonist 0C000459. Allergy[J]. 2014, 69(9) : 1223-1232.
  • 10Singh D, Cadden P, Hunter M, et al. Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 [J]. EurRespirJ, 2013, 41(1): 46-52.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部